inspiresleep.com - INSP Company Value to Revenue Ratio

Public company logo of Inspire Medical Systems, Inc. (INSP)

The price-to-sales ratio demonstrates the asset's dynamics, where the 1510.72 indicator determines the metric's value. Inspire Medical Systems (INSP) procures chips from partners, controlling only the final sterilization process. Profit growth is driven by the sale of high-margin apnea implants. The expansion of the workforce through the addition of clinicians and sales agents is proceeding as planned, maintaining the loyalty of the core development team.

INSP Inspire Medical Systems: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

INSP (Inspire Sleep): analytical breakdowns and indicator data

Fundamental valuation:Inspire Medical Systems INSP
Mass-produced product of Inspire Medical

This indicator determines the enterprise value minus net debt relative to annual revenue, allowing for an assessment of revenue generation efficiency independent of financial leverage. By analyzing the enterprise value-to-revenue ratio, an investor can identify the premium for the asset-light model of Inspire Medical Systems (INSP), where the absence of proprietary manufacturing plants reduces capital expenditures and enhances investment attractiveness.

Competitor analysis for Inspire Medical Systems

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|PROCEPT BioRobotics Inc (PRCT) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple CNMD|Company Value to Revenue Pulse Biosciences, Inc. PLSE|EV/Sales Multiple INMD (inmodemd.com)|Picard Medical Inc. - Enterprise Value-to-Revenue Ratio|SRDX - Enterprise Value-to-Revenue Ratio|SENS: Enterprise Value-to-Revenue Ratio|NPCE (NeuroPace, Inc.) - Company Value to Revenue|Tactile Systems Technology, Inc. - Business Value to Revenue|SNWV (SANUWAVE Health Inc) - EV/Sales Multiple|EV/Sales Multiple Outset Medical|Enterprise Value-to-Revenue Ratio Electromed (ELMD)|LENSAR, Inc. (LNSR) - Enterprise Value-to-Sales Ratio|AVITA Medical Inc - Company Value to Revenue|EV/Sales Multiple Profound Medical Corporation PROF|Baird Medical Investment Holdings - EV/Sales Multiple|Total Company Value-to-Revenue Ratio EDAP TMS EDAP|Apyx Medical Corporation (APYX) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume ICCM (IceCure Medical, Ltd.)|Enterprise Value-to-Revenue Ratio pulmonx.com|Company Value to Revenue TELA Bio, Inc. (TELA)|EV/Sales Multiple CTSO|SRTS - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Zynex, Inc. ZYXI|ECOR: Company Value to Revenue Ratio|RBOT: Company Value to Revenue|inspira-technologies.com - Enterprise Value-to-Revenue Coefficient|ICU: EV/Sales Multiple|IRIX - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)